IGF1 and neuroendocrine neoplasm: In addition, metformin could show positive and protective effects during endogenous GC excess via an increase of serum insulin-like growth factor-I (37) and fibroblast growth factor 21 (38–40), and/or via a suppression of neuroendocrine tumor growth (9, 41, 42).